NIMGENETICS GENÓMICA Y MEDICINA, S.L

NIMGenetics is a Spanish multinational biotechnology company specializing in the design and commercialization of clinical genetic diagnostic products and services. With a focus on microarrays and massive parallel sequencing, they offer comprehensive solutions, including pre- and post-testing support, to healthcare professionals. Their mission is to improve the health of individuals with genetic diseases and enhance the quality of life for patients and their families.

NIMGenetics has a strong presence in Spain, Portugal, Mexico, and Brazil, with a team of highly qualified geneticists. They provide a wide range of diagnostic services, including non-invasive prenatal screening, genetic risk assessments, hereditary thrombophilia studies, and molecular screening for various conditions. Additionally, they offer support services for research and pharmaceutical industries, including genome and exome sequencing, gene expression analysis, and bioinformatic services.

NIMGenetics is a Spanish biotechnology multinational dedicated to improving human health through high-quality genetic and genomic services. They offer a wide range of diagnostic tests and research services, including prenatal screening, genetic risk assessment, molecular screening, and whole-genome sequencing. Their mission is to provide healthcare professionals with the best genetic testing tools and knowledge to help improve the health and quality of life of patients with genetic diseases. They strive to be a leading player in the genetic diagnostics market and are committed to supporting research and development in the field.

NIMGENETICS promotes a culture of quality, innovation, and collaboration. They emphasize the importance of providing high-quality genetic services to patients and specialists, constantly strive to improve their offerings through research and development, and foster a team environment where everyone feels valued and empowered to contribute their expertise.